Adrenal Incidentaloma: A New Cause of the Metabolic Syndrome?
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
A number of patients with adrenal incidentaloma are exposed to a slight degree of cortisol excess resulting from functional autonomy of the adrenal mass (usually a cortical adenoma). At present, there are only scant data on the unwanted effects of this endocrine condition referred to as subclinical Cushing's syndrome. The aim of the present study was to look for some features of the metabolic syndrome in patients with incidental adrenal adenoma. Forty-one patients (9 men and 32 women) bearing adrenal incidentaloma with typical computed tomography features of cortical adenoma were studied. For both patients and controls, exclusion criteria were age equal to 70 yr or greater, previous history of fasting hyperglycemia, or impaired glucose tolerance (IGT), severe hypertension, current use of medication or concomitant relevant illnesses, and body mass index (BMI) equal to 30 kg/m(2) or greater. Forty-one patients with euthyroid multinodular goiter accurately matched for sex, age, and BMI served for a 1:1 case-control analysis. The study design included an oral glucose tolerance test (75 g) and an endocrine workup aimed at the study of the hypothalamic-pituitary-adrenal axis. Age and BMI were fully comparable between patients (54.0 +/- 10.7 yr, 23.8 +/- 2.4 kg/m(2)) and controls (52.2 +/- 11.6 yr, 23.5 +/- 2.8 kg/m(2)). Fasting glucose and fasting insulin levels were not different between the two groups (4.96 +/- 0.61 mmol/liter vs. 4.88 +/- 0.58 mmol/liter; 67 +/- 34 pmol/liter vs. 59 +/- 32 pmol/liter), but the 2-h postchallenge glucose was significantly higher in patients than in controls (7.43 +/- 2.49 mmol/liter vs. 6.10 plus minus 1.44 mmol/liter, P = 0.01). Fifteen patients (36%) reached the World Health Organization criteria for IGT and two other patients (5%) reached those for diabetes, and 14% of the controls qualified for IGT (P = 0.01). No difference in the lipid pattern was seen between the two groups, but either systolic or diastolic blood pressure were higher in patients (135.4 +/- 15.5 mm Hg vs. 125.0 +/- 15.6 mm Hg, P = 0.003; 82.9 +/- 9.1 mm Hg vs. 75.3 +/- 6.6 mm Hg, P < 0.0001). We calculated the whole-body insulin sensitivity index derived from the oral glucose tolerance test that was significantly reduced in the patients (4.3 +/- 1.7 vs. 5.7 +/- 2.5, P = 0.01). In a multiple regression analysis, 2-h glucose was associated with BMI and midnight cortisol values (r(2) = 0.36, P = 0.002). The comparison of the patients with nonfunctioning adenoma (n = 29) with those with subclinical Cushing's syndrome (n = 12) yielded significant differences as to 2-h glucose and triglyceride levels, which were significantly higher in the second group (7.02 +/- 1.76 mmol/liter vs. 8.72 +/- 3.17 mmol/liter, P = 0.03; 1.06 +/- 0.4 mmol/liter vs. 1.73 +/- 0.96 mmol/liter, P = 0.002), but the insulin sensitivity index was conversely reduced (5.2 +/- 1.4 vs. 2.9 +/- 1.2, P < 0.0001). In conclusion, many patients with incidental adrenal adenoma display altered glucose tolerance, that may be explained by reduced insulin sensitivity, and increased blood pressure levels in comparison with carefully age- and BMI-matched controls. The slight hypercortisolism observed in some such patients may significantly contribute to this state of insulin resistance. Midnight serum cortisol appears as a sensitive marker of the metabolic effects of subclinical Cushing's syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The -mg dexamethasone overnight suppression test is recommended for screening patients with AI for SCS, setting the threshold at nmol/L; a value of nmol/L virtually excludes SCS, whereas values between and nmol/L occupy an area of uncertainty ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [207]
In the citing paper
“Focusing on glucose metabolism, the prevalence of IGT or DM has been higher in patients with SCS than in cases of nonfunctioning adenoma or controls (, , , , , , ), but these data were not confirmed by other studies that found much the same prevalence of these comorbidities in SCS as in the overall series of AI and in the general population (, -).”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [207]
Citations
Cites
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898
A Survey on Adrenal Incidentaloma in Italy
Mantero, F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.637 · Cited by 855
Incidentally Discovered Adrenal Masses*
KLOOS, R. T., GROSS, M. D., FRANCIS, I. R., KOROBKIN, M., & SHAPIRO, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-4-460 · Cited by 828
Diagnosing Insulin Resistance in the General Population
McAuley, K. A., Williams, S. M., Mann, J. I., Walker, R. J., Lewis-Barned, N. J., Temple, L. A., & Duncan, A. W. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.460 · Cited by 752
Cited by
Items 101–200 of 369
Muscogiuri, G., Sorice, G. P., Prioletta, A., Mezza, T., Cipolla, C., Salomone, E., Giaccari, A., Pontecorvi, A., & Della Casa, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03928.x · Cited by 52
Adrenal Incidentaloma—A Modern Disease with Old Complications
Angeli, A., & Terzolo, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021436 · Cited by 51
Self-citationAdrenal incidentalomas and subclinical Cushing's syndrome: diagnosis and treatment.
Mazzuco, T. L., Bourdeau, I., & Lacroix, A. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832b7043 · Cited by 48
Castro, M. A., Lázaro, C. R., Ramírez, P. A. P., Hernández, M. C., Núñez, M. A. S., & Marazuela, M. (2019) · Endocrine · doi:10.1007/s12020-019-02066-w · Cited by 49
Peppa, Μ., Koliaki, C. C., & Raptis, S. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02291.x · Cited by 48
Masserini, B., Morelli, V., Palmieri, S., Eller-Vainicher, C., Zhukouskaya, V. V., Cairoli, E., Orsi, E., Beck-Peccoz, P., Spada, A., & Chiodini, I. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-014-0232-0 · Cited by 47
Modern management of mild autonomous cortisol secretion
Delivanis, D. A., Athimulam, S., & Bancos, I. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1551 · Cited by 46
Screening and diagnosis of Cushing's syndrome
Castro, M. D., & Moreira, A. C. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800004 · Cited by 34
Increased Cardiovascular Risk in Patients with Adrenal Insufficiency: A Short Review
Rahvar, A., Haas, C. S., Danneberg, S., & Harbeck, B. (2017) · BioMed Research International · doi:10.1155/2017/3691913 · Cited by 42
Possible, probable, and certain hypercortisolism: A continuum in the risk of comorbidity
Castro, M. A., Corrales, E. P., & Lamas, C. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.005 · Cited by 42
Adrenocortical tumors and insulin resistance: What is the first step?
Altieri, B., Tirabassi, G., Casa, S. D., Ronchi, C. L., Balercia, G., Orio, F., Pontecorvi, A., Colao, A., & Muscogiuri, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29950 · Cited by 40
Ivović, M., Marina, L., Vujović, S., Tančić‐Gajić, M., Stojanovic, M. M., Radonjić, N. V., Gajić, M. M., Soldatović, I., & Micić, D. (2013) · Metabolism · doi:10.1016/j.metabol.2012.12.006 · Cited by 39
Cardiovascular Risk in Patients with Nonfunctional Adrenal Incidentaloma: Myth or Reality?
Erbil, Y., Özbey, N., Barbaros, U., Ünalp, H. R., Salmaslıoğlu, A., & Özarmağan, S. (2009) · World Journal of Surgery · doi:10.1007/s00268-009-0178-0 · Cited by 39
Hidden hypercortisolism: a too frequently neglected clinical condition
Giovanelli, L., Aresta, C., Favero, V., Bonomi, M., Cangiano, B., Eller-Vainicher, C., Grassi, G., Morelli, V., Pugliese, F., Falchetti, A., et al. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01484-2 · Cited by 39
Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas
Morelli, V., Eller-Vainicher, C., Palmieri, S., Cairoli, E., Salcuni, A. S., Scillitani, A., Carnevale, V., Corbetta, S., Arosio, M., Della Casa, S., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1423 · Cited by 33
Kerstens, M. N., van der Kleij, F. G. H., Boonstra, A. H., Sluiter, W. J., Koerts, J., Navis, G. J., & Dullaart, R. P. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021625 · Cited by 37
Caetano, M. S. S., Silva, R. D. C., & Kater, C. E. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000700015 · Cited by 36
Echocardiographic alterations in patients with non-functioning adrenal incidentaloma
Ermetici, F., Dall’Asta, C., Malavazos, A. E., Coman, C., Morricone, L. F., Montericcio, V., & Ambrosi, B. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346410 · Cited by 36
Subclinical Cushing’s syndrome: Current concepts and trends
Zografos, G. N., Perysinakis, I., & Vassilatou, E. (2014) · HORMONES · doi:10.14310/horm.2002.1506 · Cited by 35
Kaštelan, D., Kraljević, I., Dušek, T., Knežević, N., Solak, M., Gardijan, B., Kralik, M., Poljičanin, T., Skoric‐Polovina, T., & Kaštelan, Ž. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0199 · Cited by 35
Kim, B., Chun, A. R., Kim, K.-J., Jung, C., Kang, S. K., Mok, J., & Kim, C. (2014) · Endocrinology and Metabolism · doi:10.3803/enm.2014.29.4.457 · Cited by 35
Aging of the Human Adrenal Cortex
Hornsby, P. J. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.35.re6 · Cited by 35
Cardiovascular mortality in patients with subclinical Cushing
Morelli, V., Arosio, M., & Chiodini, I. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.03.005 · Cited by 34
Incidentally Discovered Adrenal Mass
Song, J. H., & Mayo-Smith, W. W. (2010) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2010.10.006 · Cited by 34
Athanasouli, F., Georgiopoulos, G. A., Asonitis, N., Petychaki, F., Savelli, A., Panou, E., & Angelousi, A. G. (2021) · Endocrine · doi:10.1007/s12020-021-02741-x · Cited by 34
Emerging diagnostic methods and imaging modalities in cushing’s syndrome
Wright, K. E., van Rossum, E. F. C., Zan, E., Werner, N. L., Harris, A. G., Feelders, R. A., & Agrawal, N. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1230447 · Cited by 33
Podbregar, A., Janež, A., Goričar, K., & Jensterle, M. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00599-0 · Cited by 33
Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas?
Brossaud, J., Ducint, D., & Corcuff, J. (2016) · Clinical Endocrinology · doi:10.1111/cen.12717 · Cited by 30
Lee, S. H., Song, K., Kim, J., Park, S., Ahn, S. H., Kim, H., Cho, Y. Y., Suh, S., Kim, B., Kim, J. H., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13145 · Cited by 31
Ogura, M., Kusaka, I., Nagasaka, S., Yatagai, T., Shinozaki, S., Itabashi, N., Nakamura, T., Yokoyama, M., Ishikawa, S., & Ishibashi, S. (2003) · Endocrine Journal · doi:10.1507/endocrj.50.715 · Cited by 31
Yener, S., Ertilav, S., Seçil, M., Akıncı, B., Demir, T., Kebapçılar, L., & Yeşil, Ş. (2012) · Medical Principles and Practice · doi:10.1159/000336589 · Cited by 30
Dual-energy CT: clinical application in differentiating an adrenal adenoma from a metastasis
Shi, J., Dai, H. Z., Shen, L., & Xu, D. F. (2014) · Acta Radiologica · doi:10.1177/0284185113501660 · Cited by 30
Falcetta, P., Orsolini, F., Benelli, E., Agretti, P., Vitti, P., Cosmo, C. D., & Tonacchera, M. (2020) · Endocrine · doi:10.1007/s12020-020-02476-1 · Cited by 30
Castro, M. A., Lázaro, C. R., Ramírez, P. A. P., Centeno, R. G., Gimeno, P. G., Fernández-Ladreda, M. T., Núñez, M. A. S., Marazuela, M., Escobar-Morreale, H. F., & Valderrábano, P. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01539-y · Cited by 30
A comprehensive approach to adrenal incidentalomas
Mantero, F., & Albiger, N. M. E. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500003 · Cited by 29
Dovio, A., Allasino, B., Palmas, E., Ventura, M., Pia, A. R., Saba, L., Aroasio, E., Terzolo, M., & Angeli, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2283 · Cited by 28
Self-citationScreening for ACTH-dependent hypercortisolism in patients affected with pituitary incidentaloma
Toini, A., Dolci, A., Ferrante, E., Verrua, E., Malchiodi, E., Sala, E., Lania, A. G., Chiodini, I., Beck-Peccoz, P., Arosio, M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0599 · Cited by 26
Steffensen, C., Dekkers, O. M., Lyhne, J. D., Pedersen, B. G., Rasmussen, F., Rungby, J., Poulsen, P. L., & Jørgensen, J. O. L. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0809-3647 · Cited by 28
Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome
Muscogiuri, G., Colao, A., & Orio, F. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.07.010 · Cited by 28
Shariq, O. A., Fruth, K. M., Hanson, K. T., Cronin, P. A., Richards, M. L., Farley, D. R., Thompson, G. B., Habermann, E. B., & McKenzie, T. J. (2017) · Surgery · doi:10.1016/j.surg.2017.06.023 · Cited by 28
Goddard, G. M., Ravikumar, A., & Levine, A. C. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.009 · Cited by 28
Adrenal incidentaloma imaging – the first steps in therapeutic management
Ćwikła, J. B. (2013) · Polish Journal of Radiology · doi:10.12659/pjr.889541 · Cited by 27
Insulin resistance and adrenal incidentalomas: A bidirectional relationship
Sydney, G. I., Ioakim, K. J., & Paschou, S. Α. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.12.002 · Cited by 28
Emral, R., Aydoğan, B. İ., Köse, A. D., Demir, Ö., & Çorapçıoğlu, D. (2019) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2019.01.007 · Cited by 27
Golden, S. H., Malhotra, S., Wand, G. S., Brancati, F. L., Ford, D. E., & Horton, K. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2674 · Cited by 27
Evaluation of Functional and Malignant Adrenal Incidentalomas
Ng, V., Ma, R. C. W., So, W.-Y., Choi, K. C., Kong, A. P. S., Cockram, C. S., & Chow, C. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.441 · Cited by 25
Ueland, G. Å., Ragnarsson, Ó., Heie, A., Kjellbom, A., Lindgren, O., Muth, A., Palazzo, F. F., Poulsen, P. L., Rolighed, L., Thordarson, H. B., et al. (2025) · Endocrine Connections · doi:10.1530/ec-25-0361 · Cited by 24
Hong, N., Lee, J., Ku, C. R., Han, K., Lee, C. R., Kang, S., & Rhee, Y. (2018) · Clinical Endocrinology · doi:10.1111/cen.13902 · Cited by 24
Comorbidities in Mild Autonomous Cortisol Secretion – A Clinical Review of Literature
Czapla-Iskrzycka, A., Świątkowska−Stodulska, R., & Sworczak, K. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1827-4113 · Cited by 23
Adrenal Incidentaloma (Adrenaloma)
Linos, D. A. (2003) · HORMONES · doi:10.14310/horm.2002.1178 · Cited by 23
Khan, U. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_52_19 · Cited by 23
Virilizing Adrenal Ganglioneuroma in a Woman with Subclinical Cushing Syndrome
Diab, D. L., Faiman, C., SIPERSTEIN, A. E., Zhou, M., & Zimmerman, R. S. (2008) · Endocrine Practice · doi:10.4158/ep.14.5.584 · Cited by 23
Adrenal incidentalomas: ‘the rule of four'
Newell-Price, J. D. C., Alexandraki, K., & Grossman, A. B. (2008) · Clinical Medicine · doi:10.7861/clinmedicine.8-2-201 · Cited by 23
The functional status of incidentally discovered bilateral adrenal lesions
Androulakis, I. I., Kaltsas, G. A., Markou, A., Tseniklidi, E., Kafritsa, P., Pappa, T., Papanastasiou, L., & Piaditis, G. P. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04013.x · Cited by 22
Imga, N. N., Elalmış, Ö. U., Tuna, M. M., Dogan, B. A., Şahin, D., Berker, D. S., & Güler, S. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.37635 · Cited by 23
Incidental and Metastatic Adrenal Masses
Mannelli, M., Colagrande, S., Valeri, A., & Parenti, G. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.10.018 · Cited by 23
Is there an association between non-functioning adrenal adenoma and endothelial dysfunction?
Yener, S., Baris, M., Seçil, M., Akıncı, B., Comlekci, A., & Yeşil, S. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03347083 · Cited by 22
Ayari, H., Legedz, L., Cerutti, C., Lantelme, P., Feugier, P., Gustin, M., Lohez, O. D., Nehme, A., Li, J. Y., GHARBI-CHIHI, J., et al. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1193-7 · Cited by 21
Giant adrenal myelolipoma associated with small bowel leiomyosarcoma: a case report.
Ersoy, E., Özdoğan, M., Demirag, A., Aktimur, R., Kulaçoğlu, H., Kulaçoğlu, S., & Gündoğdu, H. (2006) · The Turkish Journal of Gastroenterology · Cited by 21
Arduç, A., Işık, S., Özuğuz, U., Tütüncü, Y., Küçükler, F. K., Özcan, H. N., Berker, D. S., & Güler, S. (2013) · Endocrine Research · doi:10.3109/07435800.2013.840653 · Cited by 20
Adrenal incidentaloma: cardiovascular and metabolic effects of mild cortisol excess
Kelsall, A., Iqbal, A., & Newell-Price, J. D. C. (2020) · Gland Surgery · doi:10.21037/gs.2019.11.19 · Cited by 20
Terzolo, M., Reimondo, G., & Angeli, A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0473 · Cited by 20
Self-citationHealth-related quality of life and fatigue in patients with adrenal incidentaloma
Kaštelan, D., Džubur, F., Dušek, T., Poljičanin, T., Crnčević-Orlić, Ž., Kraljević, I., Solak, M., Bencevic, T., Aganović, I., Knežević, N., et al. (2011) · Endocrine · doi:10.1007/s12020-011-9456-3 · Cited by 20
Anderwald, C. H., Tura, A., Gessl, A., Luger, A., Pacini, G., & Krebs, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077326 · Cited by 19
Lasco, A., Catalano, A., Pilato, A. M. C. D., Basile, G., Mallamace, A., & Atteritano, M. (2014) · PubMed · Cited by 19
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance
Muscogiuri, G., Martino, M. C. D., Negri, M., Pivonello, C., Simeoli, C., Orio, F., Pivonello, R., & Colao, A. A. L. (2017) · Endocrinology · doi:10.1210/en.2016-1804 · Cited by 20
Adrenal steroids and the metabolic syndrome
Thomson, S. P., Stump, C. S., Kurukulasuriya, L. R., & Sowers, J. R. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0093-4 · Cited by 19
Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma
Papanastasiou, L., Παππά, Θ., Samara, C., Apostolopoulou, G., Tsiavos, V., Markou, Α., Alexandraki, K., Piaditis, G. P., Chrousos, G. P., & Kaltsas, G. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02707.x · Cited by 19
Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
Szychlińska, M., Baranowska-Jurkun, A., Matuszewski, W., Wołos-Kłosowicz, K., & Bandurska-Stankiewicz, E. M. (2020) · Medicina · doi:10.3390/medicina56020069 · Cited by 18
Tzanela, M., Mantzou, A., Saltiki, K., Tampourlou, M., Kalogeris, N., Hadjidakis, D., Tsagarakis, S., & Alevizaki, M. K. (2012) · PubMed · doi:10.3275/7840 · Cited by 18
Non-functioning adrenal incidentalomas are associated with elevated D-dimer levels
Yener, S., Comlekci, A., Akıncı, B., Seçil, M., Demir, T., Ertilav, S., & Yeşil, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345724 · Cited by 18
Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas
Yılmaz, H., Tütüncü, N. B., & Şahin, M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345772 · Cited by 18
Adrenal Incidentalomas: Presentation and Clinical Work-Up
Beuschlein, F. (2007) · Hormone Research in Paediatrics · doi:10.1159/000110623 · Cited by 17
Beuschlein, F., & Reincke, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.001 · Cited by 17
Delibaşı, T., Karbek, B., Bozkurt, N. Ç., Çakır, E., Güngüneş, A., Ünsal, Ö. Ö., Aslan, M. S., & Çakal, E. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000053 · Cited by 16
Adipokine and cytokine levels in non-functioning adrenal incidentalomas (NFAI)
Babińska, A., Kaszubowski, M. F., & Sworczak, K. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej18-0066 · Cited by 16
Autonomous hypercortisolism: definition and clinical implications
Reimondo, G., Puglisi, S., Pia, A. R., & Terzolo, M. (2018) · Minerva Endocrinology · doi:10.23736/s0391-1977.18.02884-5 · Cited by 16
Self-citationStachowska, B., Kuliczkowska-Płaksej, J., Kałużny, M., Grzegrzółka, J., Jończyk, M., & Bolanowski, M. (2020) · Endocrine · doi:10.1007/s12020-020-02468-1 · Cited by 15
Kim, Y., Lee, S. W., & Lee, S. W. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17726 · Cited by 15
Cushing's syndrome of nonpituitary causes
Carroll, T. B., & Findling, J. W. (2009) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e32832d8950 · Cited by 15
Traditional and novel cardiovascular risk factors in non-functioning adrenal adenomas
Yener, S., Çömlekçi, A., Yüksel, F., Sevınç, A. I., Ertilav, S., & Yeşil, S. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.08.009 · Cited by 15
Akkuş, G., Evran, M., Sert, M., Ok, F., & Tetıker, T. (2017) · Health Science Reports · doi:10.1002/hsr2.22 · Cited by 15
Ragucci, E., Nguyen, D., Lamerson, M., & Moraitis, A. G. (2017) · Case Reports in Endocrinology · doi:10.1155/2017/6161348 · Cited by 15
Role of salivary cortisol determinations in the diagnosis of Cushing syndrome
Raff, H. (2004) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000132655.69704.8c · Cited by 15
[Laboratorial diagnosis of Cushing's syndrome].
Alves, M., Neves, C., & Medina, J. L. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.20344/amp.594 · Cited by 14
Hormonal and metabolic evaluation of adrenal incidentalomas
Wagnerová, H., Dudasova, D., & Lazúrová, I. (2009) · Neoplasma · doi:10.4149/neo_2009_06_521 · Cited by 14
Budget impact of using midnight salivary cortisol in the diagnosis of hypercortisolism
León-Justel, A., Mangas, M. A., Fontán, R. I., Luque, J. C., Moreno, E. V., Atutxa, A. M., del Rey, T. H., Martin-Rodriguez, J. F., Soto-Moreno, A., & Leal-Cerro, A. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.08.013 · Cited by 14
Donadio, F., Morelli, V., Salcuni, A. S., Eller-Vainicher, C., Carletto, M., Castellani, M., Dellavedova, L., Scillitani, A., Beck-Peccoz, P., & Chiodini, I. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346511 · Cited by 13
Ünal, A. D., Aytürk, S., Aldemir, D., & Tütüncü, N. B. (2016) · International Journal of Endocrinology · doi:10.1155/2016/8519362 · Cited by 13
BENGOA-ROJANO, N., Fernández-Argüeso, M., Botella-Carretero, J. I., Corrales, E. P., & Castro, M. A. (2022) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2022.01.003 · Cited by 13
Relationship between type 2 diabetes mellitus and hypothalamic-pituitary-adrenal axis
Felšöci, M., Schroner, Z., Petrovičová, J., & Lazúrová, I. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1497-8 · Cited by 13
Tzanela, M., Effremidis, G., Vassiliadi, D. A., Szabo, A., Gavalas, N. G., Valatsou, A., Botoula, E., & Thalassinos, N. C. (2007) · Endocrine · doi:10.1007/s12020-007-9028-8 · Cited by 13
Khawandanah, D., El-Asmar, N., & Arafah, B. M. (2018) · Endocrine · doi:10.1007/s12020-018-1769-z · Cited by 12
Ognjanovic, S. I., Μacut, D., Petakov, M. S., Kovačević, V. E., Isailovic, T. V., Antić, I. B., Ilic, D. S., Popovic, B. M., Bogavac, T., Pekmezovic, T. D., et al. (2016) · Journal of Medical Biochemistry · doi:10.1515/jomb-2016-0020 · Cited by 12
Ruiz, A., Michalopoulou, T., Megía, A., Näf, S., Simón‐Muela, I., Solano, E., Martínez, L., & Vendrell, J. J. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13048 · Cited by 12
Reliability of the diagnostic tests for Cushing’s syndrome performed in a tertiary referral center
Güneş, M., Celik, O., & Kadıoğlu, P. (2012) · Pituitary · doi:10.1007/s11102-012-0387-7 · Cited by 12
Karaköse, M., Karbek, B., Şahin, M., Arslan, M. S., Topaloğlu, O., Erden, G., Demirci, T., Çalışkan, M., & Delibaşı, T. (2015) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000008 · Cited by 12
Chen, A. X., & Burt, M. G. (2022) · Clinical Endocrinology · doi:10.1111/cen.14850 · Cited by 11
Mauclère-Denost, S., Duron-Martinaud, S., Nunes, M. L., Gatta‐Cherifi, B., Fagour, C., Rault, A., Gosse, P., & Tabarin, A. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.03.005 · Cited by 11
Puglisi, S., Leporati, M., Amante, E., Parisi, A., Pia, A. R., Berchialla, P., Terzolo, M., Vincenti, M., & Reimondo, G. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.833514 · Cited by 11
Self-citation
Metadata
- Authors
- Terzolo, M., Pia, A., Alì, A., Osella, G., Reimondo, G., Bovio, S., Daffara, F., Procopio, M., Paccotti, P., Borretta, G., & Angeli, A.
- Affiliations
- Ospedale San Luigi Gonzaga (IT)
- Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo (IT)
- Corresponding author
- Terzolo, Massimo
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2002-03
- Volume
- 87
- Issue
- 3
- Pages
- 998-1003
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2109181100
- Cited by
- 322
- References
- 44
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 3 · 2023: 16 · 2022: 9 · 2021: 11 · 2020: 11 · 2019: 9 · 2018: 16 · 2017: 10 · 2016: 7 · 2015: 18 · 2014: 15 · 2013: 16 · 2012: 20
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal incidentaloma, subclinical Cushing's syndrome, metabolic syndrome, adrenal adenoma, impaired glucose tolerance, diabetes mellitus, hypertension, hypothalamic-pituitary-adrenal axis, cortisol excess, oral glucose tolerance test, body mass index, lipid profile, insulin resistance, obesity-related hypertension, obesity-related diabetes
- MeSH terms
- Adenoma, Adrenal Gland Neoplasms, Adult, Aged, Blood Pressure, Cushing Syndrome, Female, Humans, Insulin, Male, Middle Aged, Reference Values, Body Mass Index, Case-Control Studies, Glucose Intolerance, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.